People familiar with the matter told Bloomberg that Medline is in early talks with banks about a potential listing. The company, which is the nation’s largest private manufacturer of medical supplies, could post theIPO as soon as spring 2025.
No decisions have been made about the size or timing of an IPO, the sources said.
Medline offers more than 350,000 products, partners with dozens of hospitals and health systems, and operates more than 28 million square feet of warehousing. It also owns more than 20 manufacturing plants in the U.S.
In 2023, Forbes listed Medline as the 14th largest private U.S. company.
Becker’s has reached out to Medline for comment and will update this article if more information becomes available.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.